Stimuvax cancer vaccine goes to Phase III trial

[News]

Drugmaker Merck says their experimental vaccine Stimuvax has started a Phase III clinical trial for breast cancer and lung cancer.

More... (http://www.healthcentral.com/breast-cancer/news-291002-98.html)

[chrisy]

Germany's Merck is racing with biotech firms including Transgene (TRNG.PA (http://www.reuters.com/finance/stocks/overview?symbol=TRNG.PA)), Dendreon Corp (DNDN.O (http://www.reuters.com/finance/stocks/overview?symbol=DNDN.O)) and Antigenics (AGEN.O (http://www.reuters.com/finance/stocks/overview?symbol=AGEN.O)) to bring cancer vaccines to market.

Well, keep racing, faster, and bring some effective ones across the finish line, SOON!